Jörg-Christian Hager

Title: Jörg-Christian Hager: Innovator in Aqueous Liposome Systems

Introduction

Jörg-Christian Hager is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of liposome systems. His innovative work has led to the creation of a unique aqueous liposome system that has potential applications in drug delivery.

Latest Patents

Hager holds a patent for an aqueous liposome system and a method for its preparation. This system comprises at least one phospholipid and a non-phospholipidic substance, which is a bile acid or its derivative. The mass ratio of phospholipid to the non-phospholipidic substance ranges from 1:0.001 to 1:0.1. The diameter of the liposomes formed in this system is between 35 and 90 nm. Notably, the liposome system is stable over extended periods, such as several months or years, and is highly transparent. Additionally, these liposomes can be loaded with pharmaceutically active ingredients, enhancing their utility in medical applications. Hager has 1 patent to his name.

Career Highlights

Jörg-Christian Hager is associated with A. Nattermann & Cie GmbH, where he has been instrumental in advancing research and development in liposome technology. His work has garnered attention for its innovative approach to drug formulation and delivery.

Collaborations

Hager has collaborated with notable colleagues, including Josef-Peter Löhr and Manfred Dürr. Their combined expertise has contributed to the success of various projects within the company.

Conclusion

Jörg-Christian Hager's contributions to the field of aqueous liposome systems exemplify the impact of innovation in pharmaceutical technology. His work continues to pave the way for advancements in drug delivery systems.